C
Bristol-Myers Squibb Company BMY
$46.55 $0.621.35% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 2.57% 4.62% 7.32% 5.56% 2.93%
Total Other Revenue -- -- -- -- --
Total Revenue 2.57% 4.62% 7.32% 5.56% 2.93%
Cost of Revenue 12.31% 10.45% 13.61% 10.77% 9.60%
Gross Profit -0.48% 2.78% 5.40% 4.01% 1.00%
SG&A Expenses -8.72% -5.70% 1.88% 2.03% 1.39%
Depreciation & Amortization -38.12% -19.71% -1.93% 3.79% 0.36%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -6.73% -1.86% 5.69% 5.33% 3.24%
Operating Income 41.66% 33.51% 14.15% 6.59% 1.61%
Income Before Tax 202.73% 204.48% -199.28% -179.77% -173.81%
Income Tax Expenses 1,302.75% 132.18% 38.50% 13.98% -84.86%
Earnings from Continuing Operations 177.59% 188.62% -211.11% -187.28% -181.84%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -23.08% -38.46% 0.00% 38.89% 7.14%
Net Income 177.19% 188.14% -211.50% -187.60% -182.14%
EBIT 41.66% 33.51% 14.15% 6.59% 1.61%
EBITDA 0.98% 5.59% 5.59% 5.29% 1.14%
EPS Basic 176.42% 186.41% -214.24% -190.62% -186.04%
Normalized Basic EPS 26.19% 16.94% 0.20% 3.94% 4.25%
EPS Diluted 175.75% 185.77% -214.81% -191.24% -186.76%
Normalized Diluted EPS 26.07% 16.91% 0.48% 4.37% 4.73%
Average Basic Shares Outstanding -0.14% -1.04% -2.04% -3.02% -3.55%
Average Diluted Shares Outstanding -0.04% -1.03% -2.31% -3.42% -3.98%
Dividend Per Share 3.80% 4.27% 4.76% 5.26% 5.33%
Payout Ratio 2.34% 2.17% -1.92% -2.16% -2.24%